Gritstone
Manufacturing · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(510) 871-6100Website
www.gritstone.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Gritstone
Gritstone Bio is dedicated to developing innovative immunotherapies for cancer, utilizing multi-specific antibodies to enhance the immune system's ability to target and destroy tumor cells. Their portfolio includes therapies aimed at various cancers, such as lung, gastric, esophageal, head and neck, and cervical cancers. The company collaborates with MBC Biolabs, a leading biotech incubator, to leverage state-of-the-art facilities and operational support. Gritstone Bio is committed to advancing oncological immunotherapy through a culture of teamwork and innovation.Explore more
Gritstone Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gritstone your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Gritstone has new funding data
Check out if Gritstone is spiking on competitors!
Earning: See what the market has to say on Gritstone recently announced quarterly report
Gritstone, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Gritstone has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Gritstone
Product Launch: Get notified when Gritstone launches new products
Click to see if Gritstone had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Gritstone as Masked Content
Find more new buyers
Compare Similar Companies to Gritstone
Compare insights from companies similar to Gritstone, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gritstone is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gritstone is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gritstone.
Gritstone News & Media
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the Compensation Committee of the company’s Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 39,000 shares of its common stock with an exercise price of $0.57, which is equal to the closing price of Gritstone’s common stock on July 3,Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the Compensation Committee of the company’s Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 6,850 shares of its common stock with an exercise price of $0.75, which is equal to the closing price of Gritstone’s common stock on June 7,Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
-- Favorable progression-free survival (PFS) trend observed in preliminary data from the randomized Phase 2 study evaluating GRANITE (personalized neoantigen vaccine) in front-line metastatic, microsatellite-stable colorectal cancer (MSS-CRC); mature PFS data expected in the third quarter of 2024 -- -- Nature Medicine publication of Phase 1 study of SLATE (off-the-shelf neoantigen vaccine) and AACR-presented improvements to EDGE™ (tumor antigen identification platform that was recently enhancedGritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024
-- Conference call and webcast to begin at 4:30pm ET -- EMERYVILLE, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced it will report financial results for the first quarter 2024 and provide corporate updates after market close on Thursday, May 9, 2024. The announcement will be followed by a conference call and audio webcast, which will begin
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gritstone
Sign Up For FreeTo access detailed company insights
Gritstone Bio is dedicated to developing innovative immunotherapies for cancer, utilizing multi-specific antibodies to enhance the immune system's ability to target and destroy tumor cells. Their portfolio includes therapies aimed at various cancers, such as lung, gastric, esophageal, head and neck, and cervical cancers. The company collaborates wi... Read More
